3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
13
Prostatic Neoplasms
7
Fallopian Tube Neoplasms
5
Neoplasms
3
Neoplasm Metastasis
3
Breast Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
2
Glioblastoma
2
Endometrial Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
SCLC,Extensive Stage
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Carcinosarcoma
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Castration-sensitive Prostate Cancer
1
Lung Neoplasms
1
Laryngeal Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Glioma
1
Disease Progression
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Nivolumab
5
Cyclophosphamide
5
pembrolizumab
4
Ipilimumab
4
fludarabine phosphate
3
fludarabine
3
Specimen Handling
3
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
Blood Specimen Collection
2
trametinib
1
tebentafusp
1
ruxolitinib
1
omipalisib
1
olaparib
1
lifileucel
1
binimetinib
1
belinostat
1
avelumab
1
Vorinostat
1
Valproic Acid
1
Tape Recording
1
Sunitinib
1
Spinal Puncture
1
Practice Guidelines as Topic
1
Pemetrexed
1
Methods
1
LY2940680
1
Iodized Oil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
niraparib
×
90 days
×
Clear all
No trials found.